Replies to post #216917 on Biotech Values

[GrthzGd]

Today's PR stresses IPIX's discussions with 20+ pharmas for development partnerships, that it has already engaged a bulk manufacturer, and a possible $1B market for oral mucositis alone.

Kevetrin and Prurison also hold promise. See: https://finance.yahoo.com/news/innovation-pharmaceuticals-brilacidin-franchise-anchored-140000530.html

I've been long IPIX for several years and have added on downswings. Nice increase today.